Better Explained
Gynecomastia, a condition characterized by the enlargement of breast tissue in people assigned male at birth (AMAB), can occur at any age but is most prevalent during periods of significant hormonal change, such as puberty, infancy, and old age. It is a common condition, affecting over half of AMAB individuals at some point in their lives. Gynecomastia can be categorized as physiologic or nonphysiologic.
Physiologic gynecomastia is commonly seen in newborns, adolescents, and older men. In adolescents, it can affect up to 65% of individuals, typically appearing around age 10 and peaking during ages 13 and 14. This type of gynecomastia is usually self-limiting, resolving on its own within 1–3 years as testosterone levels rise during puberty.
Nonphysiologic gynecomastia, on the other hand, can result from chronic conditions such as cirrhosis, hypogonadism, or renal insufficiency. It can also be induced by certain medications, supplements, illicit drugs, or, in rare cases, tumors. Symptoms include breast tissue swelling and tenderness, and treatment generally focuses on addressing the underlying cause. For instance, discontinuing the use of medications linked to the condition or treating the associated chronic illness may alleviate symptoms.
In some cases, gynecomastia can be treated surgically to remove excess breast tissue. Surgical options may involve liposuction, excision, or a combination of both, and are often sought by individuals looking to improve their appearance, boost self-confidence, or relieve physical discomfort.